| Literature DB >> 30727841 |
Tyler Hoffman1,2,3, Ali Khademhosseini1,2,3,4,5,6, Robert Langer7,8,9,10.
Abstract
IMPACT STATEMENT: In this Perspective, we discuss the impact of the past 25 years of tissue engineering on the development of clinical therapies. Based on their success and other significant research accomplishments, platforms of innovation were identified. Their discoveries will enable tissue engineering inspired therapies to meet the requirements necessary for large-scale manufacturing and Food and Drug Administration (FDA) approval for a diverse range of indications.Keywords: 3D bioprinting; clinical; personalized medicine; regenerative medicine; tissue engineering
Mesh:
Year: 2019 PMID: 30727841 PMCID: PMC6533781 DOI: 10.1089/ten.TEA.2019.0032
Source DB: PubMed Journal: Tissue Eng Part A ISSN: 1937-3341 Impact factor: 3.845